𝛼SK or Searchbullish
OpenEvidence At $50M/year Growing 30% MoM
182 Views17 Jul 2025 08:00
TL;DR: With doctors overwhelmed by the medical literature—which doubles in size every 5 years—OpenEvidence built a free AI-powered search engine that monetizes through pharma ads at $70-150 CPM instead of charging hospitals $500/seat like incumbent UpToDate. Sacra estimates OpenEvidence grew to $50M annualized revenue in June 2025, growing 30% MoM from $7.9M in December 2024, securing a $210M Series A from Sequoia at a $3.5B valuation for a 70x revenue multiple. For more, check out our full report and dataset on OpenEvidence...
What is covered in the Full Insight:
- Introduction to OpenEvidence
- Growth Metrics and Financial Performance
- Market Position and Competitive Landscape
- Business Model and Monetization Strategy
- Future Prospects and Upcoming Developments
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- OpenEvidence At $50M/year Growing 30% MoM17 Jul 2025
x